Loading…
Analysis of medication characteristics of traditional Chinese medicine in treating COVID-19 based on data mining
To analysis the medication characteristics of the prescriptions issued via open channel by the National and Provincial Health Committee and the State Administration of Traditional Chinese Medicine in treating coronavirus disease 2019 (COVID-19). We collected the data of traditional Chinese medicine...
Saved in:
| Published in: | Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban 2020-05, Vol.49 (2), p.260-269 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | Chinese |
| Subjects: | |
| Citations: | Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c184t-57a98bea203079d41c982c9e572f7b4e83560b39e25d5b4f0b6bd668fd3863a33 |
|---|---|
| cites | |
| container_end_page | 269 |
| container_issue | 2 |
| container_start_page | 260 |
| container_title | Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban |
| container_volume | 49 |
| creator | Fan, Tiantian Chen, Yongcan Bai, Yu Ma, Fengqi Wang, Hengcang Yang, Yiping Chen, Jinxu Lin, Yuqi |
| description | To analysis the medication characteristics of the prescriptions issued via open channel by the National and Provincial Health Committee and the State Administration of Traditional Chinese Medicine in treating coronavirus disease 2019 (COVID-19).
We collected the data of traditional Chinese medicine related to treatment plans published by the National and Provincial Health Committee and the State Administration of Traditional Chinese Medicine from the start of COVID-19 outbreak to February 19, 2020. The frequency analysis, cluster analysis and association analysis were performed.
The study collected 4 national and 34 regional prevention and treatment plans, 578 items, 84 traditional Chinese formulations, 60 Chinese patent medicines, and 230 Chinese herbs. The high frequently used herbs were
, and
. The commonly used traditional formulations included
decoction,
powder, and
decoction. The Chinese patent drugs included
pill,
injection, and
capsule. The most common paired medications were
and
and
Two core combinations and one novel formula were discovered in the study.
powder and
decoction are the basic formulations for
syndrome of COVID-19. In addition,
decoction,
powder,
decoction and
decoction are the basic formulations for
syndrome of COVID-19. The main medication characteristics are clearing heat, entilating lung, removing toxicity and removing turbidity. It shows that removing toxicity and eliminating evil are the prescription thought in treating epidemic disease of traditional Chinese medicine. |
| doi_str_mv | 10.3785/j.issn.1008-9292.2020.03.14 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2401092780</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2401092780</sourcerecordid><originalsourceid>FETCH-LOGICAL-c184t-57a98bea203079d41c982c9e572f7b4e83560b39e25d5b4f0b6bd668fd3863a33</originalsourceid><addsrcrecordid>eNo9kMtOwzAQRb0A0ar0F5AlNmwS_Ihje1mFV6VK3QDbyK9Qo8Qpsbvo32NoQbOY0Zx7rzQDwC1GJeWC3X-WPsZQYoREIYkkJUEElYiWuLoA8__1DCxj9BoxTHkudAVmlFCJa87mYL8Kqj9GH-HYwcFZb1TyY4BmpyZlkpt8TN780jQp63-g6mGz88FFd3LkEfqQucve8AGb7fv6ocASahWdhTnNqqTg4EOm1-CyU310y3NfgLenx9fmpdhsn9fNalMYLKpUMK6k0E4RRBGXtsJGCmKkY5x0XFdOUFYjTaUjzDJddUjX2ta16CwVNVWULsDdKXc_jV8HF1M7-Ghc36vgxkNsSYUwkoQLlKU3Z-lB54Pa_eQHNR3bvy_Rb7eya30</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2401092780</pqid></control><display><type>article</type><title>Analysis of medication characteristics of traditional Chinese medicine in treating COVID-19 based on data mining</title><source>PubMed Central</source><creator>Fan, Tiantian ; Chen, Yongcan ; Bai, Yu ; Ma, Fengqi ; Wang, Hengcang ; Yang, Yiping ; Chen, Jinxu ; Lin, Yuqi</creator><creatorcontrib>Fan, Tiantian ; Chen, Yongcan ; Bai, Yu ; Ma, Fengqi ; Wang, Hengcang ; Yang, Yiping ; Chen, Jinxu ; Lin, Yuqi</creatorcontrib><description>To analysis the medication characteristics of the prescriptions issued via open channel by the National and Provincial Health Committee and the State Administration of Traditional Chinese Medicine in treating coronavirus disease 2019 (COVID-19).
We collected the data of traditional Chinese medicine related to treatment plans published by the National and Provincial Health Committee and the State Administration of Traditional Chinese Medicine from the start of COVID-19 outbreak to February 19, 2020. The frequency analysis, cluster analysis and association analysis were performed.
The study collected 4 national and 34 regional prevention and treatment plans, 578 items, 84 traditional Chinese formulations, 60 Chinese patent medicines, and 230 Chinese herbs. The high frequently used herbs were
, and
. The commonly used traditional formulations included
decoction,
powder, and
decoction. The Chinese patent drugs included
pill,
injection, and
capsule. The most common paired medications were
and
and
Two core combinations and one novel formula were discovered in the study.
powder and
decoction are the basic formulations for
syndrome of COVID-19. In addition,
decoction,
powder,
decoction and
decoction are the basic formulations for
syndrome of COVID-19. The main medication characteristics are clearing heat, entilating lung, removing toxicity and removing turbidity. It shows that removing toxicity and eliminating evil are the prescription thought in treating epidemic disease of traditional Chinese medicine.</description><identifier>ISSN: 1008-9292</identifier><identifier>DOI: 10.3785/j.issn.1008-9292.2020.03.14</identifier><identifier>PMID: 32391675</identifier><language>chi</language><publisher>China</publisher><subject>Betacoronavirus - isolation & purification ; Coronavirus Infections - therapy ; COVID-19 ; Data Mining ; Drugs, Chinese Herbal - chemistry ; Drugs, Chinese Herbal - therapeutic use ; Humans ; Medicine, Chinese Traditional ; Pandemics ; Pneumonia, Viral - therapy ; SARS-CoV-2</subject><ispartof>Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban, 2020-05, Vol.49 (2), p.260-269</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c184t-57a98bea203079d41c982c9e572f7b4e83560b39e25d5b4f0b6bd668fd3863a33</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32391675$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fan, Tiantian</creatorcontrib><creatorcontrib>Chen, Yongcan</creatorcontrib><creatorcontrib>Bai, Yu</creatorcontrib><creatorcontrib>Ma, Fengqi</creatorcontrib><creatorcontrib>Wang, Hengcang</creatorcontrib><creatorcontrib>Yang, Yiping</creatorcontrib><creatorcontrib>Chen, Jinxu</creatorcontrib><creatorcontrib>Lin, Yuqi</creatorcontrib><title>Analysis of medication characteristics of traditional Chinese medicine in treating COVID-19 based on data mining</title><title>Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban</title><addtitle>Zhejiang Da Xue Xue Bao Yi Xue Ban</addtitle><description>To analysis the medication characteristics of the prescriptions issued via open channel by the National and Provincial Health Committee and the State Administration of Traditional Chinese Medicine in treating coronavirus disease 2019 (COVID-19).
We collected the data of traditional Chinese medicine related to treatment plans published by the National and Provincial Health Committee and the State Administration of Traditional Chinese Medicine from the start of COVID-19 outbreak to February 19, 2020. The frequency analysis, cluster analysis and association analysis were performed.
The study collected 4 national and 34 regional prevention and treatment plans, 578 items, 84 traditional Chinese formulations, 60 Chinese patent medicines, and 230 Chinese herbs. The high frequently used herbs were
, and
. The commonly used traditional formulations included
decoction,
powder, and
decoction. The Chinese patent drugs included
pill,
injection, and
capsule. The most common paired medications were
and
and
Two core combinations and one novel formula were discovered in the study.
powder and
decoction are the basic formulations for
syndrome of COVID-19. In addition,
decoction,
powder,
decoction and
decoction are the basic formulations for
syndrome of COVID-19. The main medication characteristics are clearing heat, entilating lung, removing toxicity and removing turbidity. It shows that removing toxicity and eliminating evil are the prescription thought in treating epidemic disease of traditional Chinese medicine.</description><subject>Betacoronavirus - isolation & purification</subject><subject>Coronavirus Infections - therapy</subject><subject>COVID-19</subject><subject>Data Mining</subject><subject>Drugs, Chinese Herbal - chemistry</subject><subject>Drugs, Chinese Herbal - therapeutic use</subject><subject>Humans</subject><subject>Medicine, Chinese Traditional</subject><subject>Pandemics</subject><subject>Pneumonia, Viral - therapy</subject><subject>SARS-CoV-2</subject><issn>1008-9292</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNo9kMtOwzAQRb0A0ar0F5AlNmwS_Ihje1mFV6VK3QDbyK9Qo8Qpsbvo32NoQbOY0Zx7rzQDwC1GJeWC3X-WPsZQYoREIYkkJUEElYiWuLoA8__1DCxj9BoxTHkudAVmlFCJa87mYL8Kqj9GH-HYwcFZb1TyY4BmpyZlkpt8TN780jQp63-g6mGz88FFd3LkEfqQucve8AGb7fv6ocASahWdhTnNqqTg4EOm1-CyU310y3NfgLenx9fmpdhsn9fNalMYLKpUMK6k0E4RRBGXtsJGCmKkY5x0XFdOUFYjTaUjzDJddUjX2ta16CwVNVWULsDdKXc_jV8HF1M7-Ghc36vgxkNsSYUwkoQLlKU3Z-lB54Pa_eQHNR3bvy_Rb7eya30</recordid><startdate>20200525</startdate><enddate>20200525</enddate><creator>Fan, Tiantian</creator><creator>Chen, Yongcan</creator><creator>Bai, Yu</creator><creator>Ma, Fengqi</creator><creator>Wang, Hengcang</creator><creator>Yang, Yiping</creator><creator>Chen, Jinxu</creator><creator>Lin, Yuqi</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20200525</creationdate><title>Analysis of medication characteristics of traditional Chinese medicine in treating COVID-19 based on data mining</title><author>Fan, Tiantian ; Chen, Yongcan ; Bai, Yu ; Ma, Fengqi ; Wang, Hengcang ; Yang, Yiping ; Chen, Jinxu ; Lin, Yuqi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c184t-57a98bea203079d41c982c9e572f7b4e83560b39e25d5b4f0b6bd668fd3863a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>chi</language><creationdate>2020</creationdate><topic>Betacoronavirus - isolation & purification</topic><topic>Coronavirus Infections - therapy</topic><topic>COVID-19</topic><topic>Data Mining</topic><topic>Drugs, Chinese Herbal - chemistry</topic><topic>Drugs, Chinese Herbal - therapeutic use</topic><topic>Humans</topic><topic>Medicine, Chinese Traditional</topic><topic>Pandemics</topic><topic>Pneumonia, Viral - therapy</topic><topic>SARS-CoV-2</topic><toplevel>online_resources</toplevel><creatorcontrib>Fan, Tiantian</creatorcontrib><creatorcontrib>Chen, Yongcan</creatorcontrib><creatorcontrib>Bai, Yu</creatorcontrib><creatorcontrib>Ma, Fengqi</creatorcontrib><creatorcontrib>Wang, Hengcang</creatorcontrib><creatorcontrib>Yang, Yiping</creatorcontrib><creatorcontrib>Chen, Jinxu</creatorcontrib><creatorcontrib>Lin, Yuqi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fan, Tiantian</au><au>Chen, Yongcan</au><au>Bai, Yu</au><au>Ma, Fengqi</au><au>Wang, Hengcang</au><au>Yang, Yiping</au><au>Chen, Jinxu</au><au>Lin, Yuqi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of medication characteristics of traditional Chinese medicine in treating COVID-19 based on data mining</atitle><jtitle>Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban</jtitle><addtitle>Zhejiang Da Xue Xue Bao Yi Xue Ban</addtitle><date>2020-05-25</date><risdate>2020</risdate><volume>49</volume><issue>2</issue><spage>260</spage><epage>269</epage><pages>260-269</pages><issn>1008-9292</issn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>To analysis the medication characteristics of the prescriptions issued via open channel by the National and Provincial Health Committee and the State Administration of Traditional Chinese Medicine in treating coronavirus disease 2019 (COVID-19).
We collected the data of traditional Chinese medicine related to treatment plans published by the National and Provincial Health Committee and the State Administration of Traditional Chinese Medicine from the start of COVID-19 outbreak to February 19, 2020. The frequency analysis, cluster analysis and association analysis were performed.
The study collected 4 national and 34 regional prevention and treatment plans, 578 items, 84 traditional Chinese formulations, 60 Chinese patent medicines, and 230 Chinese herbs. The high frequently used herbs were
, and
. The commonly used traditional formulations included
decoction,
powder, and
decoction. The Chinese patent drugs included
pill,
injection, and
capsule. The most common paired medications were
and
and
Two core combinations and one novel formula were discovered in the study.
powder and
decoction are the basic formulations for
syndrome of COVID-19. In addition,
decoction,
powder,
decoction and
decoction are the basic formulations for
syndrome of COVID-19. The main medication characteristics are clearing heat, entilating lung, removing toxicity and removing turbidity. It shows that removing toxicity and eliminating evil are the prescription thought in treating epidemic disease of traditional Chinese medicine.</abstract><cop>China</cop><pmid>32391675</pmid><doi>10.3785/j.issn.1008-9292.2020.03.14</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1008-9292 |
| ispartof | Zhejiang da xue xue bao. Journal of Zhejiang University. Medical sciences. Yi xue ban, 2020-05, Vol.49 (2), p.260-269 |
| issn | 1008-9292 |
| language | chi |
| recordid | cdi_proquest_miscellaneous_2401092780 |
| source | PubMed Central |
| subjects | Betacoronavirus - isolation & purification Coronavirus Infections - therapy COVID-19 Data Mining Drugs, Chinese Herbal - chemistry Drugs, Chinese Herbal - therapeutic use Humans Medicine, Chinese Traditional Pandemics Pneumonia, Viral - therapy SARS-CoV-2 |
| title | Analysis of medication characteristics of traditional Chinese medicine in treating COVID-19 based on data mining |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T11%3A27%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20medication%20characteristics%20of%20traditional%20Chinese%20medicine%20in%20treating%20COVID-19%20based%20on%20data%20mining&rft.jtitle=Zhejiang%20da%20xue%20xue%20bao.%20Journal%20of%20Zhejiang%20University.%20Medical%20sciences.%20Yi%20xue%20ban&rft.au=Fan,%20Tiantian&rft.date=2020-05-25&rft.volume=49&rft.issue=2&rft.spage=260&rft.epage=269&rft.pages=260-269&rft.issn=1008-9292&rft_id=info:doi/10.3785/j.issn.1008-9292.2020.03.14&rft_dat=%3Cproquest_pubme%3E2401092780%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c184t-57a98bea203079d41c982c9e572f7b4e83560b39e25d5b4f0b6bd668fd3863a33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2401092780&rft_id=info:pmid/32391675&rfr_iscdi=true |